CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Other languages Charles River Laboratories International, Inc. BOERSE MUENCHEN

Equities

RV6

US1598641074

Real-time BOERSE MUENCHEN Other stock markets 07:00:25 26/06/2024 BST			5-day change	1st Jan Change
192.1 ^EUR	+0.42%		-1.57%	-10.82%

06-25	Charles River Laboratories, Gates Institute Collaborate on Lentiviral Vector Manufacturing	MT
06-25	Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Charles River Laboratories, Gates Institute Collaborate on Lentiviral Vector Manufacturing	06-25
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus	06-25
Charles River Laboratories, Captain T Cell Enter Manufacturing Deal	06-17
Charles River Laboratories International, Inc and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy	06-17
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Lyft, Amazon, Fedex, Xpo, Vail Resorts, Unilever...	06-07
Charles River Laboratories Opens New Contract Vivarium Space in Massachusetts	06-06
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : American Airlines, Salesforce, Five Below, Tesla, Okta...	06-06
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville	06-06
Charles River Laboratories, Sanofi Collaborating to Develop Non-Animal Virtual Control Groups for Preclinical Trials	06-04
Charles River Laboratories International, Inc. Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development	05-30
Declaration of Voting Results of Charles River Laboratories International Inc	05-10
Charles River Laboratories International Q1 Non-GAAP Earnings Rise, Revenue Fall; Maintains Full Year 2024 Earnings Guidance	05-09
Charles River Laboratories International, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	05-09
Stocks Down Pre-Bell Ahead of Latest Earnings Results; Asia, Europe Churn	05-09
Charles River Laboratories International, Inc. Revises Financial Guidance for 2024	05-09
China trade heats up, UK rates in view	05-09
FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	04-25
Charles River Laboratories Files Supplement to Definitive Proxy Statement with the Securities and Exchange Commission	04-24
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing	04-16
Charles River Laboratories International, Inc. and Deciphex Limited Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology	04-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Charles River Laboratories International, Inc. BOERSE MUENCHEN

Equities

RV6

US1598641074

Other languages

Filters